AI summary by TwinMind
How I built a $275 million biotech company from nothing
Y Combinator
11m 52s
Personal Health Crisis & Inspiration
- High school student Serbi Serna experienced sharp abdominal pain, blacked out
- Initially misdiagnosed as appendicitis, avoided last-minute surgery
- Week-long diagnosis process revealed complex ovarian cysts
- Medical limitations exposed:
- Ultrasound only detects mass existence, not cancer status
- Blood tests accuracy "no better than coin toss"
- Biopsy impossible due to cancer spread risk
- Surgery requires entire ovary removal, impacting fertility
- Family chose "wait and see" approach over invasive surgery
- Cysts eventually determined non-cancerous after months
- Experience revealed antiquated women's health technology
- Wrote in high school personal statement: wanted to start women's health company
Early Career & Company Formation
- Worked as engineer at Abbott Vascular, then smaller device startup
- Despite job satisfaction and engagement, felt unsatisfied energy
- Started company at age 24 instead of gaining more industry experience
- Founded Envision Medical focused on ovarian cancer early detection
- Developed flexible metal catheter device prototypes
Customer Validation Process
- Realized need to validate concept with gynecologists
- Called own gynecologist, pretended stomach ache for appointment
- During pelvic exam, pitched catheter concept to Dr. Cook
- Dr. Cook initially startled, agreed to cafe meeting in Saratoga
- Dr. Cook liked concept, introduced to UC Davis and Stanford physicians
- Network expanded from personal connections and introduction requests
Fundraising Challenges
- Rejected by investors at least 50 times
- Faced bias as brown woman without advanced degrees (MBA, PhD, MD)
- Investor reactions to women's health:
- "Women's health isn't big enough market" (50% of population)
- Called women's health "bikini medicine"
- Two women investors agreed to invest if found third investor
- Acknowledged additional challenges for women founders due to bias
- Advised ignoring biased investors, finding supportive people
Company Development & Success
- Raised seed round, attracted world-class team
- Raised additional ~$20 million in venture capital
- Took device through prototype → clinical studies → FDA clearance
- Became first and only device cleared to collect fallopian tube cells
- Device evaluates cells for malignant features
- Goal: provide cancer answers for women with complex cysts
Acquisition by Boston Scientific
- No initial interest in acquisition, focused on patient access
- Boston Scientific and other companies interested after reading clinical data
- Received email offer: $275 million acquisition
- Described "pure disbelief" after years of rejection and funding struggles
- Signed acquisition papers on son's first birthday
- Mom and husband present at signing
- Deal completed ~6 years ago, still gives "goosebumps"
Transition to Y Combinator
- Introduced to Jared Friedman at YC post-acquisition
- YC creating first Healthcare and Bio partner position
- Spoke at YC event to 60-100 founders
- First time sharing complete story, "electrifying" room energy
- Realized experience could help other founders productively
- Became YC Group Partner
Current Role & Philosophy
- YC Group Partner focused on healthcare/bio companies
- Evaluation criteria:
- Real need being addressed
- Founder expertise in domain
- Big problem requiring solution
- Founder belief/passion level
- Not requiring MD/PhD for decision-making
- Focus on founder as right person to solve specific problem
- Mission: help founders get technologies to market faster
- Areas: agriculture, food safety, cancer medicines, early detection
- Describes role as most rewarding possible work
